CINECA IRIS Institutional Research Information System

ROSSI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.387
NA - Nord America 652
SA - Sud America 563
EU - Europa 449
Continente sconosciuto - Info sul continente non disponibili 104
AF - Africa 37
OC - Oceania 2
Totale 3.194
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 581
BR - Brasile 436
SG - Singapore 307
VN - Vietnam 301
CN - Cina 214
HK - Hong Kong 203
BD - Bangladesh 149
IT - Italia 139
DE - Germania 127
KR - Corea 113
FR - Francia 67
AR - Argentina 60
EC - Ecuador 26
ID - Indonesia 23
MX - Messico 23
CA - Canada 22
GB - Regno Unito 21
PL - Polonia 17
IN - India 15
UA - Ucraina 13
CO - Colombia 12
RU - Federazione Russa 12
IQ - Iraq 11
ZA - Sudafrica 11
EG - Egitto 8
NL - Olanda 8
PY - Paraguay 7
CL - Cile 6
CR - Costa Rica 6
ES - Italia 6
FI - Finlandia 6
VE - Venezuela 6
BG - Bulgaria 5
JM - Giamaica 5
MA - Marocco 5
PE - Perù 5
PK - Pakistan 5
SE - Svezia 5
TN - Tunisia 5
TR - Turchia 5
UY - Uruguay 5
HU - Ungheria 4
KZ - Kazakistan 4
PH - Filippine 4
SA - Arabia Saudita 4
GT - Guatemala 3
JO - Giordania 3
NP - Nepal 3
PR - Porto Rico 3
PS - Palestinian Territory 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
KE - Kenya 2
KW - Kuwait 2
PA - Panama 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
KG - Kirghizistan 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MR - Mauritania 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 3.090
Salva come PNG Salva come JPEG
Città #
Hong Kong 203
Seoul 113
Ho Chi Minh City 104
Frankfurt am Main 90
Singapore 86
Ashburn 81
Hanoi 60
Chicago 57
Beijing 53
New York 43
São Paulo 36
San Jose 32
Munich 28
Santa Clara 21
Hillsboro 20
Los Angeles 18
Rio de Janeiro 18
Haiphong 16
Da Nang 15
Naples 13
Rome 13
Curitiba 11
Mexico City 11
Warsaw 11
Buffalo 10
Dallas 10
Milan 10
Guayaquil 9
Porto Alegre 9
Seattle 9
Bexley 8
Can Tho 8
Biên Hòa 7
Salvador 7
Belo Horizonte 6
Brasília 6
Florence 6
Ha Long 6
Hải Dương 6
Montreal 6
Newark 6
Quito 6
Santo André 6
Aversa 5
Bauru 5
Brooklyn 5
Cairo 5
Fortaleza 5
Jakarta 5
Kyiv 5
London 5
Ninh Bình 5
Resistencia 5
Sorocaba 5
Stockholm 5
Thái Bình 5
Toronto 5
Turin 5
Turku 5
Wroclaw 5
Asunción 4
Baghdad 4
Barbacena 4
Bologna 4
Buenos Aires 4
Bắc Ninh 4
Campinas 4
Campo Grande 4
Council Bluffs 4
Formosa 4
Juiz de Fora 4
Kingston 4
Lima 4
Recife 4
Roubaix 4
San José 4
Sofia 4
Abbeville 3
Amman 3
Atlanta 3
Cape Town 3
Charlotte 3
Contagem 3
Guarujá 3
Guarulhos 3
Jacareí 3
Johannesburg 3
Lakeland 3
Limeira 3
Madrid 3
Montevideo 3
Mumbai 3
Natal 3
Nha Trang 3
Petrópolis 3
Phoenix 3
Phủ Lý 3
Praia Grande 3
Reston 3
Serra 3
Totale 1.516
Salva come PNG Salva come JPEG
Nome #
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 132
Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database - A Case Study 86
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects 67
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 66
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System 62
Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study 61
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta‐blocker use: a Danish nationwide cohort study 60
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 56
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database 56
Current and future therapeutic perspective in chronic heart failure 56
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 55
Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study 54
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System 51
Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomerase 50
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 49
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 48
Diabetes-Induced Cellular Senescence and Senescence-Associated Secretory Phenotype Impair Cardiac Regeneration and Function Independently of Age 47
COVID-19 and atrial fibrillation: Intercepting lines 47
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 47
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 46
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 45
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 45
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 45
Deficit of glucocorticoid-induced leucine zipper amplifies angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction 44
Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? 44
Glucocorticoid-induced leucine zipper (Gilz) in cardiovascular health and disease 43
Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury 43
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome 43
Current pharmacological treatments for COVID-19: What's next? 42
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting 42
Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity 41
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study 41
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? 40
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management 40
Pharmacological, Technological, and Digital Innovative Aspects in Rhinology 40
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 40
Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data 39
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 39
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 39
Tisagenlecleucel in children and young adults: Reverse translational research by using real‐world safety data 39
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years 39
Statins stimulate new myocyte formation after myocardial infarction by activating growth and differentiation of the endogenous cardiac stem cells 38
The safety profile of general and local anaesthetic agents: Data collected during 20 years of spontaneous reporting activities in the campania region (southern italy) 37
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 37
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 36
Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines 36
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 36
We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database 36
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines 35
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase® 35
Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study 35
Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch 35
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment 34
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 34
A case of figurate urticaria by etanercept 34
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review 34
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 34
Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study 33
Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey 32
The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review 32
Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System 32
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 32
Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis 31
Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System 31
Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study 30
Effects of sacubitril-valsartan on aging-related cardiac dysfunction 29
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting syste 28
The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure 28
Relationship Between Gender and the Effectiveness of Montelukast: An Italian/Danish Register-Based Retrospective Cohort Study 28
Therapeutic strategies to fight COVID‐19: Which is the status artis? 27
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 27
Utilizing clinical pharmacology in the drug repurposing arena: a look into COVID-19 26
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 23
Unmasking counterfeit semaglutide: analysis of real-world safety data from EudraVigilance 23
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 23
Intervention studies and antimicrobial resistance in Italy: An overview of the latest evidence 19
Italian immunization goals: A political or scientific heated debate? 12
Safety profile of FLT3 inhibitors in acute myeloid leukemia: a systematic review and meta-analysis of adverse events 8
Semaglutide Exposure During Pregnancy: Results from the FAERS Database 3
Corrigendum to "LONG-TERM inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice" [Exp. Gerontol. (2010) 202-207] 2
Totale 3.194
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.969
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025584 0 0 0 3 39 173 70 50 45 46 117 41
2025/20262.426 147 133 408 525 207 66 43 170 181 249 161 136
2026/2027184 58 114 12 0 0 0 0 0 0 0 0 0
Totale 3.194